Dyne Therapeutics Inc (DYN)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $3.13B
Last updated: Nov 17, 2026 at 4:15 PM ET
Dyne Therapeutics Inc (DYN) Stock Chart
Dyne Therapeutics (DYN) has a latest price of $16.02 on Nov 17, 2026, 41.3% below its 52-week high of $27.30. Its price fell 14.7% over the past 12 months. The month-end price rose 15.0% over the 5 years through Oct 2026, a compound annual rate of 2.8%.
Price Chart
From Sep 2020 to Oct 2026, its highest month-end close was $46.09 in Aug 2024 and its lowest $4.81 in May 2022, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart DYN with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for DYN.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price fell 40.2%, and over 6 months it rose 0.6%. The month-end price rose 136.7% over the 3 years through Oct 2026, a compound annual rate of 33.3%.
| Period | Change |
|---|---|
| 1 month | +5.2% |
| 3 months | -40.2% |
| 6 months | +0.6% |
| 12 months | -14.7% |
| 12 months, with dividends | -14.7% |
| Period | Change | Per year |
|---|---|---|
| 3 years | +136.7% | +33.3% |
| 5 years | +15.0% | +2.8% |
Price by Year
Its best calendar year was 2024, when the price rose 77.1%, and its weakest was 2021, when it fell 43.4%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $16.69 | -14.7% |
| 2025 | $19.56 | -17.0% |
| 2024 | $23.56 | +77.1% |
| 2023 | $13.30 | +14.8% |
| 2022 | $11.59 | -2.5% |
| 2021 | $11.89 | -43.4% |
Trading Range
The price is 4.2% below its 50-day average of $16.72 and 17.0% below its 200-day average of $19.30.
| Measure | Value | Price vs |
|---|---|---|
| Latest price (Nov 17, 2026) | $16.02 | |
| 52-week high | $27.30 | -41.3% |
| 52-week low | $14.00 | +14.4% |
| 50-day average | $16.72 | -4.2% |
| 200-day average | $19.30 | -17.0% |
Price Risk
Over 3 years, its largest fall from a peak was 85.5%.
| Measure | Value |
|---|---|
| 1-year beta | 1.80 |
| Largest fall, 1 year | -46.8% |
| Largest fall, 3 years | -85.5% |
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About DYN
What is DYN's 1-year price change?
Dyne Therapeutics's price fell 14.7% over the past 12 months. With dividends included, the 12-month total return was -14.7%.
What is DYN's 5-year price change?
Dyne Therapeutics's month-end price rose 15.0% over the 5 years through Oct 2026, a compound annual rate of 2.8%. These figures leave out dividends.
What is DYN's 52-week high and low?
Dyne Therapeutics's 52-week high is $27.30 and its 52-week low is $14.00. Its latest price of $16.02 on Nov 17, 2026 is 41.3% below the high.
What is DYN's beta?
Dyne Therapeutics's 1-year beta against the S&P 500 is 1.80, so its price has moved more than the market over the past year. Its largest fall from a peak over the past year was 46.8%.
Is the DYN chart free?
Yes. Advanced Charting for DYN is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
DYN pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Competitors